Breye Therapeutics
Series ACopenhagen, DenmarkOct 2026
Breye Therapeutics raised €68M in a Series A round in Oct 2026. The company is based in Copenhagen, Denmark. Investors in the round: Catalyze Capital, EIFO, Innovestor Life Science Fund and 6 others. Data as of Nov 2026.
Amount raised
€68M
€67,500,000
Native amount
67,500,000 EUR
Stage
Series A
series a
Investors
9
Provenance & confidence
High confidenceAmount
Reported in EUR — no conversion. €68M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
9 namedCatalyze CapitalEIFOInnovestor Life Science FundLjungström family officeMission BioCapitalModi VenturesNovo HoldingsPappas CapitalSound Bioventures
Date
Oct 2026
Round type
series a
Amount (EUR)
€68M